Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › ACVR2A-specific antibody and method of treatment of muscle atrophy

ACVR2A-specific antibody and method of treatment of muscle atrophy

US Patent 11104737 · Granted Aug 31, 2021

Estimated economic value: $9,467,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods related to tumor activated antibodies targeting EGFR an2025
TGF-β inhibitors2025
Compositions and methods related to tumor activated antibodies targeting EGFR an2024
TGF-β inhibitors2022
TGF-beta inhibitors2022
Method of using a bispecific antibody to conditionally inhibit a receptor signal2021
Method of using a bispecific antibody to conditionally inhibit a receptor signal2021
Method of using a bispecific antibody to conditionally inhibit a receptor signal2021
TGF-ß inhibitors2021
2,3-Disubstituted pyridine compounds as TGF-β inhibitors and methods of use2020
TGF-β inhibitorC2020
In vivo engineered cereblon protein2020